TELIX PHARMACEUTICALS, INC.

Lobbying client · Indiana · filed 2025 to 2026

Pharmaceutical Company

$143,000 Reported spend

5 Filings counted

1 Outside firm hired

0 Bills named

Spend is reported income plus in-house expenses across 5 filings. Everything on this page comes from one LDA client record (55694), filed by the registrant listed below.

Who filed for this client 1

HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C. $143,000 Outside firm · 5 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Reported by year 2 years

2026 $0 1 filing
2025 $143,000 4 filings

Issues lobbied 1

Medicare/Medicaid 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 5
SENATE 5

Recent filings 5 total

Q1 termination

HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · posted Apr 7, 2026

View → Q4 report

HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $13,000 income · posted Jan 8, 2026

View → Q3 report

HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $26,000 income · posted Oct 2, 2025

View → Q2 report

HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $65,000 income · posted Jul 9, 2025

View → Q1 report

HALL, RENDER, KILLIAN, HEATH & LYMAN, P.C.

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $39,000 income · posted Apr 9, 2025

View →

Keep going

Filings through April 7, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.